ArticleCost effectiveness and resource allocation : C/E2022

Do Health Technology Assessment organisations consider manufacturers' costs in relation to drug price? A study of reimbursement reports.

Joost J Enzing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.